Hsiang‐Wen Lin

790 total citations
38 papers, 558 citations indexed

About

Hsiang‐Wen Lin is a scholar working on Geriatrics and Gerontology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, Hsiang‐Wen Lin has authored 38 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Geriatrics and Gerontology, 8 papers in General Health Professions and 8 papers in Economics and Econometrics. Recurrent topics in Hsiang‐Wen Lin's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Medication Adherence and Compliance (6 papers). Hsiang‐Wen Lin is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Medication Adherence and Compliance (6 papers). Hsiang‐Wen Lin collaborates with scholars based in Taiwan, United States and Vietnam. Hsiang‐Wen Lin's co-authors include A. Simon Pickard, Andrew Lloyd, Caitlyn T. Wilke, Yen‐Ming Huang, Chien‐Ning Hsu, You‐Lin Tain, Swu‐Jane Lin, Chia‐Ing Li, Cheng‐Chieh Lin and Chiahung Chou and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and International Journal of Environmental Research and Public Health.

In The Last Decade

Hsiang‐Wen Lin

32 papers receiving 550 citations

Peers

Hsiang‐Wen Lin
Hsiang‐Wen Lin
Citations per year, relative to Hsiang‐Wen Lin Hsiang‐Wen Lin (= 1×) peers Ana Paula Martins

Countries citing papers authored by Hsiang‐Wen Lin

Since Specialization
Citations

This map shows the geographic impact of Hsiang‐Wen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsiang‐Wen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsiang‐Wen Lin more than expected).

Fields of papers citing papers by Hsiang‐Wen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsiang‐Wen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsiang‐Wen Lin. The network helps show where Hsiang‐Wen Lin may publish in the future.

Co-authorship network of co-authors of Hsiang‐Wen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Hsiang‐Wen Lin. A scholar is included among the top collaborators of Hsiang‐Wen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsiang‐Wen Lin. Hsiang‐Wen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Huang, Hui‐Chi, Jui‐Ming Liu, Guanlin Chen, et al.. (2024). Inhibition of Autophagy Aggravates Arachis hypogaea L. Skin Extracts-Induced Apoptosis in Cancer Cells. International Journal of Molecular Sciences. 25(2). 1345–1345. 8 indexed citations
4.
Lin, Hsiang‐Wen, Chih‐Jung Chen, Hwei-Chung Wang, et al.. (2024). Monitoring trends in the absolute lymphocyte count and the neutrophil-to-lymphocyte ratio in patients with breast cancer receiving eribulin. BMC Cancer. 24(1). 195–195.
5.
Chen, Chia‐Wen, et al.. (2023). Innovative analysis of diazepam, zolpidem and their main metabolites in human urine by micelle-to-solvent stacking in capillary electrophoresis. Journal of Pharmaceutical and Biomedical Analysis. 239. 115898–115898. 1 indexed citations
6.
Huang, Yen‐Ming, et al.. (2023). Impacts of medication non-adherence to major modifiable stroke-related diseases on stroke prevention and mortality: a meta-analysis. Journal of Neurology. 270(5). 2504–2516. 12 indexed citations
7.
Lin, Hsiang‐Wen, et al.. (2023). A non-invasive mouse model that recapitulates disuse-induced muscle atrophy in immobilized patients. Scientific Reports. 13(1). 22201–22201. 3 indexed citations
8.
Lin, Hsiang‐Wen, Chen‐Yuan Lin, Yu‐Chieh Chen, et al.. (2023). Quality of care in the course of subcutaneous versus intravenous trastuzumab administration in patients with breast cancer: an integrated time–motion study with mixed-methods research. BMJ Open. 13(3). e059288–e059288. 6 indexed citations
9.
Hsu, Chien‐Ning, You‐Lin Tain, Pei‐Chen Lu, & Hsiang‐Wen Lin. (2023). Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses. Health and Quality of Life Outcomes. 21(1). 117–117. 6 indexed citations
11.
Yang, Zhihao, Fredrick Dermawan Purba, Asrul Akmal Shafie, et al.. (2022). Do health preferences differ among Asian populations? A comparison of EQ-5D-5L discrete choice experiments data from 11 Asian studies. Quality of Life Research. 31(7). 2175–2187. 8 indexed citations
12.
Nguyen, Son Truong, et al.. (2022). Quality of Life and Its Associated Factors Among Cancer Patients Receiving Chemotherapy at Oncology Hospitals in Vietnam After the Third Wave of the COVID-19 Pandemic. Cancer Management and Research. Volume 14. 2429–2444. 5 indexed citations
13.
Huang, Yen‐Ming, et al.. (2021). Ideal instruments used to measure health literacy related to medication use: A systematic review. Research in Social and Administrative Pharmacy. 17(10). 1663–1672. 8 indexed citations
14.
Lin, Hsiang‐Wen, et al.. (2020). Evolution of clinical pharmacy practice and pharmacy education in Taiwan, Vietnam, and Indonesia: A narrative review. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 947–958. 7 indexed citations
15.
Shapiro, Nancy L., Hsiang‐Wen Lin, & Alan H. Lau. (2020). Creation and delivery of a clinical pharmacy practice and education program for international participants in the United States. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 3(5). 913–919.
16.
Tsai, Daniel Hsiang‐Te, et al.. (2019). Predicting the serum digoxin concentrations of infants in the neonatal intensive care unit through an artificial neural network. BMC Pediatrics. 19(1). 517–517. 12 indexed citations
17.
Hsu, Chien‐Ning, Hsiang‐Wen Lin, A. Simon Pickard, & You‐Lin Tain. (2018). EQ-5D-Y for the assessment of health-related quality of life among Taiwanese youth with mild-to-moderate chronic kidney disease. International Journal for Quality in Health Care. 30(4). 298–305. 25 indexed citations
18.
Lin, Hsiang‐Wen, Chih‐Hsueh Lin, Che‐Yi Chou, et al.. (2017). Economic outcomes of pharmacist-physician medication therapy management for polypharmacy elderly: A prospective, randomized, controlled trial. Journal of the Formosan Medical Association. 117(3). 235–243. 44 indexed citations
19.
Lin, Hsiang‐Wen, et al.. (2017). Uncertain Associations of Major Bleeding and Concurrent Use of Antiplatelet Agents and Chinese Medications: A Nested Case‐Crossover Study. Evidence-based Complementary and Alternative Medicine. 2017(1). 9417186–9417186. 3 indexed citations
20.
Lin, Hsiang‐Wen, et al.. (2012). A nationwide evaluation on electronic medication‐related information provided by hospital websites. Journal of Evaluation in Clinical Practice. 19(2). 304–310. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026